I-DXd

· Daiichi Sankyo

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for I-DXd, covering 2026-02-06 to 2026-02-06. Get the full timeline:

Most recent: Clinical Trial Update: A Study of I-DXd in Combination With Atezolizumab With or Without Carboplatin as First-Line Induction or Maintenance in Subjects With Extensive Stage-Small Cell Lung Cancer (IDeate-Lung03) [Phase 1, Phase 2]

See pricing